Verona Pharma to Present at Jefferies 2017 Global Healthcare Conference

Verona Pharma plc (AIM:VRP) (NASDAQ:VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on developing and commercialising innovative therapeutics for the treatment of respiratory diseases with significant unmet medical needs, announced today that Jan-Anders Karlsson, PhD, CEO of Verona Pharma, is scheduled to present at the Jefferies 2017 Global Healthcare Conference.

An audio webcast of the presentation will be available on the Investors section of the company website, www.veronapharma.com.  A replay of the webcast will be made available for 90 days following the presentation.

Event: Jefferies Healthcare ConferenceDate: June 8, 2017Time: 11:30 AM EDT Location: New York, NY

For further information, please contact:

Verona Pharma plc						Tel: [phone]
Jan-Anders Karlsson, Chief Executive Officer						[e-mail]
N+1 Singer (Nominated Adviser and UK Broker)						Tel: [phone]
Aubrey Powell / James White
FTI Consulting (UK Media and Investor enquiries)						Tel: [phone]
Simon Conway / Stephanie Cuthbert / Natalie Garland-Collins						[e-mail]
ICR, Inc. (US Media and Investor enquiries)
James Heins						Tel: +1 [e-mail]
Stephanie Carrington						Tel. +1 [e-mail]